Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Significance: This report reveals the influence of sialylation on the activation of epidermal growth factor receptor (EGFR) and sensitivity to tyrosine kinase inhibitors (TKIs) against EGFR phosphorylation. By utilizing biochemical approaches, we demonstrated that EGFR sialylation suppresses EGFR phosphorylation by inhibiting EGF binding and EGFR dimerization. In the TKI-resistant lung cancer cell line with L858R/T790M mutations on EGFR, the levels of phosphorylation at Y1068, Y1086, and Y1173 are upregulated, and sialylation can partially suppress the phosphorylation of EGFR at these sites and enhance EGFR sensitivity to TKI. These findings suggest that sialylation has an important role in tumorigenesis and sensitivity to TKIs by modulating EGFR phosphorylation and the associated signaling network and provide insights for therapeutic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a similar vein, both sialylation and fucosylation modulate epidermal growth factor receptor-mediated intracellular signaling (528 -530).”
From Biological roles of glycans (2017) · cites this paper as [530]
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,411
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
Yun, C.-H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.017 · Cited by 1,192
Research works printed but not linked: 1
- 10.1128/mcb.14.8.5192-5201.1994 · doi:10.1128/mcb.14.8.5192-5201.1994 · Paper page
Cited by
Items 101–122 of 122
Li, D., Hua, Y., Jiang, L., Huang, Y., Yue, J., Wu, Y. R., & Chen, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.905892 · Cited by 3
Self-citationShang, D., Chen, C., Dong, X., Cui, Y., Qiao, Z., Li, X., & Liang, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1011851 · Cited by 3
Martínez-Alarcón, D., Castro-Guillén, J. L., Fitches, E., Gatehouse, J. A., Przyborski, S. A., Moreno‐Celis, U., Blanco‐Labra, A., & García-Gasca, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413258 · Cited by 3
Cell surface glycoproteomics: deciphering glycoproteins through a unique analytical capture approach
Huang, S., Wang, X., Zhang, P., & Yang, S. (2023) · Analytical Methods · doi:10.1039/d3ay00982c · Cited by 2
Leong, S. K., Hsiao, J., & Shie, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158754 · Cited by 2
Anim, M. T., Tuffour, I., Willis, R., Schell, M., Ostlund, T., Mahnashi, M. H., Halaweish, F. T., & Willand‐Charnley, R. (2023) · Molecules · doi:10.3390/molecules28176257 · Cited by 2
Rybak, A., Zarzecki, M., Golabiewska, E., Niechoda, A., & Hołownia, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_329 · Cited by 2
From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer
Lai, B., Xu, C., Lai, S., Zhou, M., Kong, H., Kong, E., & Yahaya, B. H. (2026) · Cancer Drug Resistance · doi:10.20517/cdr.2025.231 · Cited by 4
Zhang, N., Song, G., Peng, Z., Du, K., Cai, C., Miao, S., Tang, Y., Wang, Y., & Li, J. (2026) · Small Methods · doi:10.1002/smtd.70912 · Cited by 1
Self-citationCell Surface Sialylated N-Glycan Alterations during Development
Karaçalı, S. (2017) · European Journal of Biology · doi:10.5152/eurjbiol.2017.1714 · Cited by 1
Highlights in Chemical Glycobiology
Wong, C., & Krasnova, L. B. (2018) · Israel Journal of Chemistry · doi:10.1002/ijch.201800139 · Cited by 1
Self-citationGastrodin has in vitro anticancer effects in human glioma U118 cells
Yang, Y., Cui, H., & Wang, X. (2017) · Biomedical Research-tokyo
Chemical labeling and analysis of sialoglycans
Cheng, B., & Chen, X. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0207
Irani, M. A., & Ejtehadi, M. R. (2020) · doi:10.22541/au.158802236.65289521
Tumor Proliferation Through Sialic Acid Dynamics and Anti-Siglec-Sialoglycans Preventive Strategies
Nguyen, P. (. (2022) · International journal of high school research · doi:10.36838/v4i6.14
Mahalapbutr, P. (2018) · Chula Digiverse · doi:10.58837/chula.the.2018.11
Hamamura, K., Nagao, M., & Furukawa, K. (2025) · Oral Science International · doi:10.1002/osi2.70016
Hassan, A. A., Chen, Q., Fung, K. S. W., To, S. K. Y., Cheung, L. W. T., Zhang, C., Liu, N., Lok, C. N., Che, C., Ip, P. P. C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.17.682592
Miró Domènech, L. (2023) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Ivanusic, D., Zipf, G., Maier, J., Bernauer, H. S., & Bannert, N. (2026) · iScience · doi:10.1016/j.isci.2026.115185
Increase in Sialylated EGFR Levels by Arsenite Enhances EGF‐Dependent EGFR Phosphorylation
Sumi, D., Nakahira, S., Taguchi, H., Nakayama, A., Nakayama, R., & Fujishiro, H. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70308
Wu, X., & Mao, X. (2026) · International Journal of Medical Sciences · doi:10.7150/ijms.124859
Metadata
- Authors
- Yen, H.-Y., Liu, Y.-C., Chen, N.-Y., Tsai, C.-F., Wang, Y.-T., Chen, Y.-J., Hsu, T.-L., Yang, P.-C., & Wong, C.-H.
- Affiliations
- Institute of Biochemical Sciences and
- Genomics Research Center,
- National Yang Ming University (TW)
- National Taiwan University (TW)
- Institute of Chemistry (CN)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-05-13
- Volume
- 112
- Issue
- 22
- Pages
- 6955-6960
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4460513
- OpenAlex
- W1554182554
- Cited by
- 119
- References
- 47
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 9 · 2022: 13 · 2021: 14 · 2020: 11 · 2019: 13 · 2018: 14 · 2017: 11 · 2016: 11
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- EGFR phosphorylation, tyrosine kinase inhibitor resistance, gefitinib resistance, lung cancer, receptor dimerization, autophosphorylation, neuraminidase, sialyltransferase inhibitors, desialylation, EGF binding
- MeSH terms
- Gefitinib, Enzyme Inhibitors, Humans, Models, Molecular, Neuraminidase, Phosphorylation, Protein Binding, Protein-Tyrosine Kinases, Quinazolines, Dimerization, Mutation, Missense, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.